期刊文献+

82例胃炎、胃溃疡患者的不合理用药分析及总结 被引量:6

下载PDF
导出
摘要 目的总结胃炎、胃溃疡患者治疗中的不合理用药情况,为临床治疗提供参考。方法回顾性分析笔者所在医院消化内科门诊就诊的82例胃炎、胃溃疡患者临床用药情况,对其中存在的不合理用药进行分析。结果胃炎及胃溃疡主要治疗药物有:抗酸药(H:受体拮抗剂、胆碱药物、质子泵抑制剂等)、胃黏膜保护剂、抗幽门螺杆菌药物等。调查结果显示不合理用药的比率约为47.6%(39/82);不合理用药主要是药物配伍的不科学。结论临床医生特别是基层医务人员应了解不同药物的作用机制,合理用药,避免不合理用药发生。
作者 潘时良
出处 《中国医学创新》 CAS 2011年第6期170-171,共2页 Medical Innovation of China
  • 相关文献

参考文献3

二级参考文献23

  • 1樊景堂.胃酸与消化性溃疡的关系及药物的临床选用[J].中国社区医师(医学专业),2007,9(6):10-10. 被引量:2
  • 2R Nagashima. Mechanisms of action of sucralfate[J]. CliGastroenterol, January, 1981, 3(Suppl 2): 117-127.
  • 3Nagashima R,Hirahara Y, Hirano T, et al. Selective binding of sucralfate to ulcer lesion. Ⅱ. Experiments in rats with gastric ulcer receiving 14C sucralfate or potassium 14C-sucrose sulfate[J]. Arzneimittelforsehung, 1980,30 ( 1 ) : 84.
  • 4Kinoshita M, Yamasaki K, Kokusenya Y,et al. Relationship between gastroprotective effect of locally acting antiulcer agent ecabet sodium and its binding to gastric mucosa in rats comparison with sucralfate[J]. Dig Dis Sci, 1995, 40:661-667.
  • 5Guth PH, Aures D, Paulson G. Topical aspirin plus HCL gastric lesions in the rat[J]. Gastroenterology, 7979,76( 1 ) : 88 -93.
  • 6Cristina Sola Larranaga, Inigo Navarro-Blaseo. Chemometrie analysis of minerals and trace elements in raw cow milk from the community of Navarra, Spain[J]. Food Chemistry, 112, (2009) : 189-196.
  • 7Hossam MM, Arafa A, Mohamed M. Sayea-Ahmed. Protective role of carnitine esters against alcohol-induced gastric lesions in rats [J]. Pharmacological Research, 48, (2003) : 285- 290.
  • 8Martindale M. Martindale, the Complete Drug Reference, 31th Edition[M]. London:The Pharmaceutical Press, 1996, 1243.
  • 9T hoh, K Kusaka, K Kawaura, etal. Selective Binding of Sucralfate to Endoscopic Mucosal Resection-induced Gastric Ulcer:Evaluation of Aluminium Adherence[J]. The Journal of International Medical Research, 2004,32 : 520-529.
  • 10卢文丽,方肇勤,潘志强,侯俐,刘小美.6种胃溃疡小鼠模型的证候特征及比较[J].上海中医药杂志,2007,41(8):63-68. 被引量:25

共引文献21

同被引文献26

  • 1张小仙.健胃消胀合剂对慢性胃炎、胃溃疡治疗作用的实验研究[c].//第二十一届全国脾胃病学术交流会论文集.2009:320-322.
  • 2尤启冬.孙铁民,杨晓红,等.国家执业药师资格考试应试指南药学专业知识(二)[M].北京:中国医药科技出版社,2011:512-515.
  • 3Den Hollander W J,Kuipers E J.Current pharmacotherapy options for gastritis[J]. Expert Opin Pharmacother,2012; 13( 18):2625-2636.
  • 4Lee J S,Cho J Y, Song H,et aI.Revaprazan,a novel acid pump antagonist,exerts anti- intlammatory action against llelicobacter pylori-induced COX-2 expression by inactivating Akt signaling[ J].J Clin Biochem Nutr,2012;51(2):77-83.
  • 5Lee Y C,Chang C H,Lin J W, et aI.Non-steroidal anti-inflammatory drugs use and risk of upper gastrointestinal adverse events in cirrhotic patients[J].Liver Int,2012;32(5):859-866.
  • 6李馨嫱.急、慢性胃炎合理用药[J].中外健康文摘,2009;6(34):123-4124.
  • 7Akyildiz M,Akay S,Musoglu A.Tbe efficacy of ranitidine bismuth citrateamoxicillin and doxycycl ine or tetracycline regimens as a first line treatment for Helicobacter pvlorieradication[J].Eur J Intern Med,2009:20(1):53-57.
  • 8Van Rensburg C,Barkun AN,Racz J.Clinical trial:intravenous pantoprazole vs ranitidine for the prevetation of pepticulcer rebleeding:a multicentre, multinational,randomized trial [J].Aliment Pharmacol Ther,2009;29(5):497-507.
  • 9李冬华,陈晏湖.消化系疾病治疗学[M].北京:人民卫生出版社.2005,149.
  • 10张成拴.2004~2006年我院抗酸药及抗溃疡药临床应用分析[J].中国医院用药评价与分析,2008,8(6):424-426. 被引量:3

引证文献6

二级引证文献27

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部